Rasha Omr Abd Elmonem Ahmed
Asst. Professor
Impact of Hepatitis C Virus Infection and Direct-acting Oral Antiviral Drugs on Glycaemic State in Type 2 Diabetic Patients
• 2026
Publication Information
Authors
Ayman ElBadawy, Mohamed El sayed, Islam Abdellatif, Rasha AbdelMoneim,
Keywords
Not Available
Journal
Not Available
Publisher
Not Available
Volume
Not Available
Issue
Not Available
Pages
Not Available
publication.type
Local
Paper Link
Not Available
Supplementary Materials
Not Available
Abstract
Background: Diabetes mellitus (DM) is strongly associated with
chronic hepatitis C virus (HCV) infection. This work aimed to estimate
the impact of Hepatitis C virus infection on glycaemic state and insulin
resistance in type 2 Diabetic patients, and evaluate the effect of directacting oral antiviral treatment on the glycaemic state and insulin
resistance in type 2 Diabetic patients. Methods: The study was
performed on (40 patients) with Type 2 Diabetes who were infected by
Hepatitis C Virus and took Direct-acting Oral Antiviral Drugs. The
study also included (10 patients) who had Type 2 Diabetes and HCV
infection serving as control group. All patients and control were
subjected to thorough history taking, clinical examination, and lab.
investigations as FBG, PP and HBA1c , Serum fasting Insulin level,
And HOMA-IR, HCVAb – HBsAg – HIVAb, CBC, SGOT, SGPT,
Serum Albumin and Bilirubin, PCR for HCV RNA, and Abdominal
US. Results: DAAs-based eradication of HCV is associated with
improved glycemic control in patients with type 2 diabetes as evidenced by a significant reduction
of mean FBG, Fasting insulin, HbA1c, and HOMA IR. There was a positive correlation between
the treatment of HCV infection and the reduction of anti-diabetic drugs used in the studied
patients. Conclusion: DAAs-based eradication of HCV is associated with improved glycemic
control in patients with type 2 diabetes.
chronic hepatitis C virus (HCV) infection. This work aimed to estimate
the impact of Hepatitis C virus infection on glycaemic state and insulin
resistance in type 2 Diabetic patients, and evaluate the effect of directacting oral antiviral treatment on the glycaemic state and insulin
resistance in type 2 Diabetic patients. Methods: The study was
performed on (40 patients) with Type 2 Diabetes who were infected by
Hepatitis C Virus and took Direct-acting Oral Antiviral Drugs. The
study also included (10 patients) who had Type 2 Diabetes and HCV
infection serving as control group. All patients and control were
subjected to thorough history taking, clinical examination, and lab.
investigations as FBG, PP and HBA1c , Serum fasting Insulin level,
And HOMA-IR, HCVAb – HBsAg – HIVAb, CBC, SGOT, SGPT,
Serum Albumin and Bilirubin, PCR for HCV RNA, and Abdominal
US. Results: DAAs-based eradication of HCV is associated with
improved glycemic control in patients with type 2 diabetes as evidenced by a significant reduction
of mean FBG, Fasting insulin, HbA1c, and HOMA IR. There was a positive correlation between
the treatment of HCV infection and the reduction of anti-diabetic drugs used in the studied
patients. Conclusion: DAAs-based eradication of HCV is associated with improved glycemic
control in patients with type 2 diabetes.